Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales ...

Cosmos and Globus, part of the Globus family of brands (GFOB), launch exciting deals and discounts for tours departing 2025 ...

Come From Away” stars light up the Globus Theatre stage June 14 with their tribute to movie and musical love songs via ...

Two mostly vacant office buildings in Montgomery County lost the majority of their value in a foreclosure sale.

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Zimmer Biomet named Kevin Thornal as group president for global business and the Americas, according to a May 27 news release. Mr. Thornal will join the company July 1. He was previously CEO and ...

Fintel reports that on May 27, 2025, BTIG downgraded their outlook for Globus Medical (NYSE:GMED) from Buy to Neutral. Analyst Price Forecast Suggests 68.61% Upside As of May 7, 2025, the average ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high estimate of $82.00, and a low estimate of $68.00. A negative shift in sentiment is ...

Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.